The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Regulatory CD56 bright natural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis
Abstract
Administration of daclizumab, a humanized mAb directed against the IL-2Rα chain, strongly reduces brain inflammation in multiple sclerosis patients. Here we show that daclizumab treatment leads to only a mild functional blockade of CD4 + T cells, the major candidate in multiple sclerosis pathogenesis. Instead, daclizumab therapy was associated with a gradual decline in circulating CD4 + and CD8 + T cells and significant expansion of CD56 bright natural killer (NK) cells in vivo , and this effect correlated highly with the treatment response. In vitro studies showed that NK cells inhibited T cell survival in activated peripheral blood mononuclear cell cultures by a contact-dependent mechanism. Positive correlations between expansion of CD56 bright NK cells and contraction of CD4 + and CD8 + T cell numbers in individual patients in vivo provides supporting evidence for NK cell-mediated negative immunoregulation of activated T cells during daclizumab therapy. Our data support the existence of an immunoregulatory pathway wherein activated CD56 bright NK cells inhibit T cell survival. This immunoregulation has potential importance for the treatment of autoimmune diseases and transplant rejection and toward modification of tumor immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The biology of human natural killer-cell subsets
Cooper, M. A., Fehniger, T. A., & Caligiuri, M. A. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02060-9 · Cited by 2,975
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher-Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,856
Determination of lymphocyte division by flow cytometry
Lyons, A. B., & Parish, C. R. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90236-4 · Cited by 1,657
Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset
Cooper, M. A., Fehniger, T. A., Turner, S. C., Chen, K. S., Ghaheri, B. A., Ghayur, T., Carson, W. E., & Caligiuri, M. A. (2001) · Blood · doi:10.1182/blood.v97.10.3146 · Cited by 1,449
Setoguchi, R., Hori, S., Takahashi, T., & Sakaguchi, S. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041982 · Cited by 1,235
Carson, W. E., Giri, J. G., Lindemann, M. J., Linett, M. L., Ahdieh, M., Paxton, R., Anderson, D., Eisenmann, J., Grabstein, K., & Caligiuri, M. A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.4.1395 · Cited by 1,092
Fehniger, T. A., Cooper, M. A., Nuovo, G. J., Cella, M., Facchetti, F., Colonna, M., & Caligiuri, M. A. (2003) · Blood · doi:10.1182/blood-2002-09-2876 · Cited by 857
A humanized antibody that binds to the interleukin 2 receptor.
Queen, C., Schneider, W. P., Selick, H. E., Payne, P. W., Landolfi, N. F., Duncan, J. F., Avdalovic, N. M., Levitt, M., Junghans, R. P., & Waldmann, T. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.10029 · Cited by 627
Self-citationT cell fitness determined by signal strength
Gett, A. V., Sallusto, F., Lanzavecchia, A., & Geginat, J. (2003) · Nature Immunology · doi:10.1038/ni908 · Cited by 473
Immune Responses in Interleukin-2-Deficient Mice
Kündig, T. M., Schorle, H., Bachmann, M. F., Hengartner, H., Zinkernagel, R. M., & Horak, I. (1993) · Science · doi:10.1126/science.8235625 · Cited by 462
Caligiuri, M. A., Zmuidzinas, A., Manley, T. J., Levine, H., Smith, K. A., & Ritz, J. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.5.1509 · Cited by 435
Sadlack, B., Löhler, J., Schorle, H., Klebb, G., Haber, H., Sickel, E., Noelle, R. J., & Horak, I. (1995) · European Journal of Immunology · doi:10.1002/eji.1830251111 · Cited by 423
Regulation of Experimental Autoimmune Encephalomyelitis by Natural Killer (NK) Cells
Zhang, B.-N., Yamamura, T., Kondo, T., Fujiwara, M., & Tabira, T. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.10.1677 · Cited by 364
Bielekova, B., Richert, N., Howard, T., Blevins, G., Markovic-Plese, S., McCartin, J., Würfel, J., Ohayon, J., Waldmann, T. A., McFarland, H. F., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402653101 · Cited by 315
Self-citationThe role of different subsets of T regulatory cells in controlling autoimmunity
Roncarolo, M.-G., & Levings, M. K. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00162-x · Cited by 310
Nussenblatt, R. B., Fortin, E., Schiffman, R., Rizzo, L., Smith, J., Van Veldhuisen, P., Sran, P., Yaffe, A., Goldman, C. K., Waldmann, T. A., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7462 · Cited by 259
Self-citationActivated, But Not Resting, T Cells Can Be Recognized and Killed by Syngeneic NK Cells
Rabinovich, B. A., Li, J., Shannon, J., Hurren, R., Chalupny, J., Cosman, D., & Miller, R. G. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3572 · Cited by 223
A subset of natural killer cells is greatly expanded within inflamed joints
Dalbeth, N., & Callan, M. F. C. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10410 · Cited by 210
Interleukin-2, Interleukin-15, and Their Receptors
Waldmann, T., Tagaya, Y., & Bamford, R. (1998) · International Reviews of Immunology · doi:10.3109/08830189809042995 · Cited by 192
Self-citationKikuchi-Maki, A., Yusa, S.-I., Catina, T. L., & Campbell, K. S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3415 · Cited by 182
Natural killer cells and autoimmunity
French, A. R., & Yokoyama, W. (2003) · Arthritis Research & Therapy · doi:10.1186/ar1034 · Cited by 144
The use of antibodies against the IL-2 receptor in transplantation.
Waldmann, T., & O'Shea, J. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80215-x · Cited by 139
Self-citationNishikawa, K., Saito, S., Morii, T., Hamada, K., Ako, H., Narita, N., Ichijo, M., Kurahayashi, M., & Sugamura, K. (1991) · International Immunology · doi:10.1093/intimm/3.8.743 · Cited by 113
The IL-2/IL-15 Receptor Systems: Targets for Immunotherapy
Waldmann, T. A. (2002) · Journal of Clinical Immunology · doi:10.1023/a:1014416616687 · Cited by 99
Self-citationSmeltz, R. B., Wolf, N. A., & Swanborg, R. H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1390 · Cited by 83
Trotta, R., Parihar, R., Yu, J., Becknell, B., Allard, J., Wen, J., Ding, W., Mao, H., Tridandapani, S., Carson, W. E., et al. (2004) · Blood · doi:10.1182/blood-2004-10-4072 · Cited by 81
Lehky, T. J., Levin, M. C., Kubota, R., Bamford, R. N., Flerlage, A. N., Soldan, S. S., Leist, T. P., Xavier, A., White, J. D., Brown, M., et al. (1998) · Annals of Neurology · doi:10.1002/ana.410440613 · Cited by 80
Self-citationControl of Autoimmunity by Regulatory T Cells
Shevach, E. M., McHugh, R. S., Thornton, A. M., Piccirillo, C. A., Natarajan, K., & Margulies, D. H. (2001) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1243-1_3 · Cited by 80
Cited by
Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
Morgan, R. A., Chinnasamy, N., Abate-Daga, D., Gros, A., Robbins, P. F., Zheng, Z., Dudley, M. E., Feldman, S. A., Yang, J. C., Sherry, R. M., et al. (2013) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3182829903 · Cited by 1,148
Self-citationMalek, T. R. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090357 · Cited by 1,079
Multiple sclerosis: a complicated picture of autoimmunity
McFarland, H. F., & Martin, R. (2007) · Nature Immunology · doi:10.1038/ni1507 · Cited by 985
Self-citationCD56bright natural killer (NK) cells: an important NK cell subset
Poli, A., Michel, T., Thérésine, M., Andrès, E., Hentges, F., & Zimmer, J. (2009) · Immunology · doi:10.1111/j.1365-2567.2008.03027.x · Cited by 977
Multiple Sclerosis: Mechanisms and Immunotherapy
Baecher-Allan, C., Kaskow, B. J., & Weiner, H. L. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.021 · Cited by 938
Metadata
- Authors
- Bielekova, B., Catalfamo, M., Reichert-Scrivner, S., Packer, A., Cerna, M., Waldmann, T. A., McFarland, H., Henkart, P. A., & Martin, R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2006-04-11
- Volume
- 103
- Issue
- 15
- Pages
- 5941-5946
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2113485611
- Cited by
- 597
- References
- 28
- FWCI
- 11.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.